Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Stomach Neoplasms 4Gastritis 4Peptic Ulcer 3Lymphoma, B-Cell, Marginal Zone 3Dyspepsia 3Lymphoma 2Unspecified Adult Solid Tumor, Protocol Specific 1Stomach Ulcer 1Rosacea 1Meibomian Gland Dysfunction 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Gastritis Dyspepsia Helicobacter Pylori Infection Gastric Cancer Peptic Ulcer 1Exanthema 1Dysbiosis 1Chalazion 1Ameloblastoma 1

Interventions

Gels 2Fulvestrant 2Doxycycline 2Dapsone 2ruxolitinib 1dexpanthenol 1ceterizine hydrochloride 1capivasertib 1benralizumab 1Triamcinolone Acetonide 1Tetracycline 1Sirolimus 1Provitamins 1Prednisone 1Panitumumab 1Minocycline 1Loperamide 1Irinotecan 1IFL protocol 1Hydrocortisone 1Erlotinib Hydrochloride 1Clindamycin 1Cetuximab 1Anti-Bacterial Agents 1Alpelisib 1Acitretin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Exanthema × Tetracycline × Clear all
NCT01880515 2025-05-11

Tetracycline as a Prophylaxis for Rash in Patients With NSCLC Receiving Treatment With BIBW2992 (Afatinib)

Instituto Nacional de Cancerologia de Mexico

Phase 2 Completed
107 enrolled 8 charts
Thoracic

Exanthema, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡